Cited by 151Cutaneous Melanoma Detection and ManagementMobile Health and mHealth Applicationsmelanin and skin pigmentation

Smartphone applications for melanoma detection by community, patient and generalist clinician users: a review

Open access
Kassianos, A.P., Emery, J.D., Murchie, P., Walter, F.M.·2015·British Journal of Dermatology

Abstract

Smartphone health applications ('apps') are widely available but experts remain cautious about their utility and safety. We reviewed currently available apps for the detection of melanoma (July 2014), aimed at general community, patient and generalist clinician users. A proforma was used to extract and assess each app that met the inclusion criteria, and we undertook content analysis to evaluate their content and the evidence applied in their development. Thirty-nine apps were identified with the majority available only for Apple users. Over half (n = 22) provided information or education about melanoma, ultraviolet radiation exposure prevention advice, and skin self-examination strategies, mainly using the ABCDE (A, Asymmetry; B, Border; C, Colour; D, Diameter; E, Evolving) method. Half (n = 19) helped users take and store images of their skin lesions either for review by a dermatologist or for self-monitoring to identify change, an important predictor of melanoma; a similar number (n = 18) used reminders to help users monitor their skin lesions. A few (n = 9) offered expert review of images. Four apps provided a risk assessment to patients about the probability that a lesion was malignant or benign, and one app calculated users' future risk of melanoma. None of the apps appeared to have been validated for diagnostic accuracy or utility using established research methods. Smartphone apps for detecting melanoma by nonspecialist users have a range of functions including information, education, classification, risk assessment and monitoring change. Despite their potential usefulness, and while clinicians may choose to use apps that provide information to educate their patients, apps for melanoma detection require further validation of their utility and safety.

AI snapshot

Written from the paper’s full text.

TL;DR

This review identified 39 smartphone apps available in July 2014 for melanoma detection by community, patient, and generalist clinician users, most of which provided information, image capture/storage, or lesion monitoring. None appeared validated for diagnostic accuracy or utility, and only four apps provided lesion risk assessment.

Key findings

  • Of 39 included apps, 26 (66.7%) were Apple-only, 8 (20.5%) Android-only, and 5 (12.8%) available on both; 28 were free, with paid apps ranging from £0.69 to £4.99.
  • The commonest function was general information about melanoma/skin cancer (n = 22); 19 apps catalogued/classified lesions by capturing images, 18 used image analysis, 18 aimed to monitor skin lesions, and 9 offered expert image review.
  • Only 4 apps provided risk assessment for whether a lesion was malignant or benign, and one app calculated future melanoma risk using eight risk factors to estimate 5-year absolute risk.
  • None of the apps appeared validated for diagnostic accuracy or utility using established research methods; only one app acknowledged research/development processes, and clinician involvement was clearly stated in only four apps.

Methods

  • In July 2014, the authors searched Apple and Android online stores using terms including “skin cancer,” “mole,” and “melanoma,” including apps stating an aim to help detect melanoma and excluding entertainment, cosmetics-only, general medical information-only, specialist-only/dermoscopy, and non-English apps.
  • A proforma was used by one researcher to extract data from online app descriptions only; no apps were downloaded. Data covered operating system, research/validation status, latest update, and functions including information/education, risk factor assessment, image analysis/cataloguing, and monitoring changes.
  • Content analysis and critical appraisal were performed independently by two researchers, with categories refined and differences resolved by consensus among the wider research team.

Limitations

  • The paper states the review was restricted to online store descriptions, did not purchase or use apps, included only English-language apps, and covered only Apple and Android platforms.
  • The paper notes that more information may have been available after purchasing or using apps, but this was not done to ensure equity across the review.
  • Evident from the text: the review could not assess actual diagnostic performance, safety, or clinical utility because no apps were validated or tested against a reference standard in the included material.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1111/bjd.13665

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Claims the paper makes

0 of 32 cited sources checked · 0 supported · 0 flagged

  • Findingown data

    Thirty-nine unique smartphone apps met the inclusion criteria for this review.

    “We identified 39 unique smartphone apps that met our inclusion criteria (Tables 1 and 2).”
    Quote in the paperSubstantial claim
  • Findingown data

    Only four apps provided tools to assess a skin lesion for likelihood of melanoma.

    “Only four apps provided tools to assess a skin lesion for likelihood of melanoma.”
    • Also stated in: § Abstract · plain
      “Four apps provided a risk assessment to patients about the probability that a lesion was malignant or benign”
    Quote in the paperNot a substantial claim
  • Findingown data

    Eighteen apps aimed to monitor skin lesions.

    “Nineteen apps catalogued and classified lesions by capturing images, and applying integral algorithms, and 18 apps aimed to monitor skin lesions.”
    Quote in the paperNot a substantial claim
    • Rests on an assumption: Change in a skin lesion is an important predictor of melanoma.
  • Findingown data

    Seven apps provided limited or no information on how photographic images were processed and analysed to provide advice on likelihood of melanoma.

    “It was noteworthy that seven apps (Mole Detective, Mole Monitor, Skin of Mine, Skin Prevention -Photo Body Map, Skin Scanner, Skin Vision, SkinXM) provided limited or no information on how the photographic images were processed and analysed to provide advice on likelihood of melanoma.”
    Quote in the paperNot a substantial claim
  • Findingnone given

    A single app (UMSkinCheck) offered assessment of a person's baseline risk factor, using eight risk factors to calculate 5-year absolute risk for melanoma.

    “A single app offered assessment of a person's baseline risk factor: UMSkinCheck used eight risk factors (region, sex, race, age, complexion, tanning, small moles and freckling) to calculate 5-year absolute risk for melanoma.”
    Quote in the paperNot a substantial claim
  • Classified as probably not a substantial claim. 29
  • May combine two claims. 20
  • The quote only partly states this claim. 2
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Findingown data

    One app (UMSkinCheck) stated it was specifically designed for non-Hispanic white U.S. citizens.

    “One app (UMSkinCheck) stated it was specifically designed for non-Hispanic white U.S. citizens.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingcitation

    Only one app acknowledged any research and developmental processes; the Melanoma Visual Risk Calculator was based on the diagnostic value of the ABCDE criteria for patient users.

    “Even though several of the apps incorporated the ABCDE method, only one app acknowledged any research and developmental processes; the Melanoma Visual Risk Calculator was based on the diagnostic value of the ABCDE criteria for patient users.17”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [17] Thomas, 1998, Semiological value of ABCDE criteria in the diagnosis of cutaneous pigmented tumors, Dermatology source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Findingown data

    The Melanoma Visual Risk Calculator provided a risk approximation based on patients' responses to a VAS.

    “The Doctor Mole and Skin Doctor apps used a computerized algorithm based on the ABCDE method, and the Melanoma Visual Risk Calculator provided a risk approximation based on patients' responses to a VAS.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Findingown data

    Four apps offered guidance on how to find a dermatologist in the U.S.A.

    “Four apps (Dermatology Planet, iDoc24, Skin Cancer, Skin of Mine) also offered guidance on how to find a dermatologist in the U.S.A.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Findingown data

    Most apps (n=28) were available to download for free, with the remaining apps having an added cost (range £0.69-£4.99).

    “Most of the apps (n = 28) were available to download for free, with the remaining apps having an added cost to download (range £0Á69-£4Á99).”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Findingnone given

    iSkin claimed to gather information about a mole and then calculate risk of melanoma, but provided no further information about the method involved.

    “iSkin claimed to gather information about a mole and then calculate risk of melanoma, but provided no further information about the method involved.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingnone given

    There was little evidence of clinical or research-based input into the design of these apps or of evaluation of their utility.

    “There was little evidence of clinical or research-based input into the design of these apps or of evaluation of their utility, so clinicians should be cautious about supporting the use of such apps to detect melanoma.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Findingnone given

    Using smartphone apps to monitor skin lesions was undertaken via the storage of photographic images, and users were encouraged to track the evolution of individual lesions by comparing serial images over time.

    “Using smartphone apps to monitor skin lesions was undertaken via the storage of photographic images of their skin lesions.Users were encouraged to track the evolution of individual lesions by comparing serial images over time.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Findingnone given

    The technology can use a 'teledermatology' model, and send the image for expert review and advice.

    “Furthermore, the technology can use a 'teledermatology' model, and send the image for expert review and advice.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Findingown data

    Some apps used simple comparisons with stored images, while others used more sophisticated algorithms.

    “While some such as Doctor Mole and Skin Prevention used simple comparisons with stored images, others used more sophisticated algorithms, such as Skin Analytics, which claimed to use 'real time vision technology'.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    There is surprisingly scanty scientific evidence about the development or evaluation of the smartphone apps included in the review; only one app provided a single reference to a peer-reviewed publication.

    “We also found surprisingly scanty scientific evidence about the development or evaluation of the smartphone apps included in our review; only one app provided a single reference to a peer-reviewed publication.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Findingnone given

    Most apps identified were developed in the U.S.A.

    “Most apps that we identified were developed in the U.S.A.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).

    Findingnone given

    Three apps (Doctor Mole -Skin Cancer app, Mollie's Fund, n evus) had their Apple and Android versions updated in different years.

    “Three apps (Doctor Mole -Skin Cancer app, Mollie's Fund, n evus) had their Apple and Android versions updated in different years.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Findingnone given

    These apps also suggested that users could share the images during consultations with their dermatologist or family physician.

    “These apps also suggested that users could share the images during consultations with their dermatologist or family physician.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Findingown data

    Some apps provided feedback to patients based on the ABCDE method; others allowed users to set reminders to take another photograph for comparison after a selected time.

    “Some, such as the Doctor Mole app, provided feedback to patients based on the ABCDE method; others, such as the Embarrassing Bodies -My Mole-Checker and the Mole Detective apps allowed users to set reminders to take another photograph for comparison after a selected time.”
    Quote in the paperNot a substantial claim
  • The quote only partly states this claim.

    Findingown data

    22 of the reviewed apps provided melanoma/skin cancer information and/or education.

    “Total | 22 | 6 | 15 | 4 | 18 | 9 | 19”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing). The quote only partly states this claim.

    Findingown data

    9 of the reviewed apps provided dermatologist review.

    “Total | 22 | 6 | 15 | 4 | 18 | 9 | 19”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S2 (checkable).

    Interpretationreasoning

    Clinicians should be cautious about supporting the use of such apps to detect melanoma.

    “There was little evidence of clinical or research-based input into the design of these apps or of evaluation of their utility, so clinicians should be cautious about supporting the use of such apps to detect melanoma.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S1 (asserted), S3 (load-bearing).

    Premisecitation

    Apps for detecting cancers tend to lack scientific and specialty input.

    “It has also been suggested that apps for detecting cancers tend to lack scientific and specialty input, 8”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [8] O'Neill, 2012, Colorectal smartphone apps: opportunities and risks, Colorectal Dis source

      Not checked in the free run.

  • May combine two claims.

    Premisecitation

    Reviews of smartphone apps for dermatology in general and for colorectal cancer have reported similar findings of scanty scientific evidence.

    “Reviews of smartphone apps for dermatology in general, 7,11 and for colorectal cancer, 8 have reported similar findings.”
    Quote in the paperNot a substantial claim0 of 3 sources checked
    • cites [7] Wolf, 2013, Diagnostic inaccuracy of smartphone applications for melanoma detection, JAMA Dermatol source

      Not checked in the free run.

    • cites [11] Hamilton, 2012, Medical professional involvement in smartphone ‘apps’ in dermatology, Br J Dermatol source

      Not checked in the free run.

    • cites [8] O'Neill, 2012, Colorectal smartphone apps: opportunities and risks, Colorectal Dis source

      Not checked in the free run.

  • May combine two claims.

    Interpretationreasoning

    Smartphone apps have the potential to improve patient and nonspecialist clinician assessment and patient-clinician communication about potential skin cancer.

    “Therefore, while they have the potential to improve patient and nonspecialist clinician assessment and patient-clinician communication about potential skin cancer there is the risk that these apps could actually harm users.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Premisecitation

    Smartphone apps for melanoma detection could actually harm users, for example by providing inaccurate or misleading advice, being used as a substitute for clinical consultation, or delaying melanoma diagnosis.

    “The advice could be inaccurate or misleading, apps could be used as a substitute for a clinical consultation, and they could even delay melanoma diagnosis.12”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites [12] Robson, 2012, Caution in melanoma risk analysis with smartphone application technology, Br J Dermatol source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Study design and conductnone given

    The proforma was completed based only on the online descriptions; no apps were downloaded for data extraction purposes.

    “The proforma was completed based only on the online descriptions; no apps were downloaded for data extraction purposes.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    A recently published systematic review found only two randomized studies that had used smartphone technology.

    “a recently published systematic review found only two randomized studies that had used smartphone technology.9”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [9] Dickinson, 2014, Using technology to deliver cancer follow-up: a systematic review, BMC Cancer source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    A recent report highlighted the diagnostic inaccuracies of four smartphone apps for melanoma detection, with wide variations in sensitivity and specificity to detect malignant skin lesions.

    “a recent report highlighted the diagnostic inaccuracies of four smartphone apps for melanoma detection, with wide variations in sensitivity and specificity to detect malignant skin lesions.7”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [7] Wolf, 2013, Diagnostic inaccuracy of smartphone applications for melanoma detection, JAMA Dermatol source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Interpretationown data

    Image analysis allows for self-monitoring, and the use of reminders and alerts promote the added use of monitoring skin changes over time.

    “For example, image analysis allows for self-monitoring, and the use of reminders and alerts promote the added use of monitoring skin changes over time.”
    Quote in the paperNot a substantial claim
    • Rests on an assumption: Change in a skin lesion is an important predictor of melanoma.
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    Two out of three U.S. clinicians already use smartphone health apps in their practice to manage a range of conditions.

    “two out of three U.S. clinicians already use smartphone health apps in their practice to manage a range of conditions. 1”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [1] Senior, 2011, Smart phones: new clinical tools in oncology?, Lancet Oncol source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    Many experts remain cautious about the utility of the thousands of apps currently available for the prevention, detection and management of cancer.

    “many experts remain cautious about the utility of the thousands of apps currently available, either free or at a small charge, for the prevention, detection and management of cancer.6,7”
    Quote in the paperNot a substantial claim0 of 2 sources checked
    • cites [6] Bender, 2013, A lot of action, but not in the right direction: systematic review and content analysis of smartphone applications for the prevention, detection, and management of cancer, J Med Internet Res source

      Not checked in the free run.

    • cites [7] Wolf, 2013, Diagnostic inaccuracy of smartphone applications for melanoma detection, JAMA Dermatol source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Premisecitation

    The revised 'Glasgow' 7-point checklist was developed and recently validated in a U.K. primary care population.

    “particularly for use in the U.K. population where it was developed and recently validated in a primary care population.29”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [29] Walter, 2013, Using the 7-point checklist as a diagnostic aid for pigmented skin lesions in general practice: a diagnostic validation study, Br J Gen Pract source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    Another recent review has identified patients as having a stronger desire to be informed about underpinning scientific evidence than commercial stakeholders.

    “Another recent review has also identified patients as having a stronger desire to be informed about underpinning scientific evidence than commercial stakeholders.32”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [32] Dehzad, 2014, Adopting health apps, what's hindering doctors and patients?, Health source

      Not checked in the free run.

  • Classified as probably not a substantial claim.

    Interpretationnone given

    This review is the first to outline the content of available apps, whether they are derived from research evidence, and whether they have been validated.

    “It is also the first review to outline the content of available apps, whether they are derived from research evidence, and whether they have been validated.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Interpretationreasoning

    It is likely that small platforms would use the same apps as some were available via both of the major platforms, and the authors are therefore confident that few are missing.

    “It is likely that small platforms would use the same appsas some were available via both of the major platformsand we are therefore confident that few are missing.”
    Quote in the paperNot a substantial claim
  • Classified as probably not a substantial claim. May combine two claims.

    Study design and conductreasoning

    The review was restricted to the descriptions available from the online stores; more information may have been available after purchasing or using the apps, but this was not undertaken to ensure equity across the review.

    “It was restricted to the descriptions available from the online stores; more information may have been available after purchasing or using the apps, but this was not undertaken in order to ensure equity across the review.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    The European Medicines Agency has signalled similar intentions to regulate mobile health software.

    “the European Medicines Agency has signalled similar intentions.34”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [34] European Medicines Agency Guidelines on the qualification and classification of stand alone software used in healthcare within the regulatory framework of medical devices http://ec.europa.eu/health/medical-devices/files/meddev/2_1_6_ol_en.pdf

      Not checked in the free run.

  • May combine two claims.

    Study design and conductreasoning

    The review included only apps available in English; therefore it may have failed to identify apps published in other languages.

    “We reviewed apps only available in English; therefore we may have failed to identify any apps published in other languages.”
    Quote in the paperNot a substantial claim
  • Classified as probably not a substantial claim. May combine two claims.

    Study design and conductreasoning

    The review only reviewed apps applicable to Apple and Android phones because more than 90% of apps are available via these two platforms.

    “Finally, we only reviewed apps applicable to Apple and Android phones as we knew that more than 90% of apps are available via these two platforms.”
    Quote in the paperSubstantial claim
    • Rests on an assumption: More than 90% of smartphone apps are available via Apple and Android platforms.
  • May combine two claims.

    Premisecitation

    A recent systematic review mapping mobile health research over the last decade identified 117 publications, but concluded that few included large or rigorous evaluation of the novel technologies.

    “A recent systematic review mapping mobile health research over the last decade identified 117 publications, but concluded that few included large or rigorous evaluation of the novel technologies.31”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites [31] Fiordelli, 2013, Mapping mHealth research: a decade of evolution, J Med Internet Res source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Premisecitation

    The U.S. Food and Drug Administration (FDA) does not currently regulate the mobile health industry, but there are plans to do so in a similar way to regulation for medical devices.

    “although the U.S. Food and Drug Administration (FDA) does not currently regulate the mobile health industry, there are plans to do so in a similar way to regulation for medical devices; 33”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [33] U.S. Food and Drug Administration Mobile Medical Applications http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/ConnectedHealth/MobileMedicalApplications/ucm255978.htm

      Not checked in the free run.

    • Rests on an assumption: The U.S. Food and Drug Administration (FDA) does not currently regulate the mobile health industry.
38 of 38
  • The paper relies on this without support.

    Change in a skin lesion is an important predictor of melanoma.

    “an important predictor of melanoma”
    “an important predictor of melanoma”
  • The paper relies on this without support.

    Earlier detection of melanoma would allow timely treatment and could improve outcomes.

    “Earlier detection of melanoma would allow timely treatment and could improve outcomes.”
  • The paper relies on this without support.

    Smartphone apps for the identification or management of cancer including melanoma have not been subject to any sort of validation or regulatory controls in the U.S.A., the U.K. or elsewhere.

    “Furthermore, smartphone apps for the identification or management of cancer including melanoma have not been subject to any sort of validation or regulatory controls in the U.S.A., the U.K. or elsewhere.”
  • The paper relies on this without support.

    Online store descriptions of apps are sufficient to evaluate app content and allow users to make an informed choice.

    “we felt that users should be able to make an informed choice about the apps by reading their description in the online stores.”
  • The paper relies on this without support.

    More than 90% of smartphone apps are available via Apple and Android platforms.

    “we knew that more than 90% of apps are available via these two platforms.”
  • The paper relies on this without support.

    The mobile health app market is unregulated.

    “particularly as the market is unregulated”
  • The paper relies on this without support.

    The ABCDE method is widely used in the U.S.A.

    “where the ABCDE method is widely used”
  • The paper relies on this without support.

    The U.S. Food and Drug Administration (FDA) does not currently regulate the mobile health industry.

    “although the U.S. Food and Drug Administration (FDA) does not currently regulate the mobile health industry”
8 of 8

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Kassianos, A. P., Emery, J. D., Murchie, P., & Walter, F. M.
Affiliations
  • University of Cambridge (GB)
  • The University of Melbourne (AU)
  • University of Aberdeen (GB)
Corresponding author
Walter, F.M.
Venue
British Journal of Dermatology
Published
2015-05-06
Volume
172
Issue
6
Pages
1507-1518
ISSN
0007-0963 (ISSN-L)
OpenAlex
W1998412697
Cited by
151
References
32
Citations by year
2026: 8 · 2025: 6 · 2024: 8 · 2023: 11 · 2022: 8 · 2021: 11 · 2020: 21 · 2019: 18 · 2018: 20 · 2017: 21 · 2016: 13 · 2015: 6
FWCI
2.15
Type
journal article
Language
en
Open access
Locations
  • British Journal of Dermatology (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • Ktisis at Cyprus University of Technology (Cyprus University of Technology) (submittedVersion, cc-by-nc-nd)
  • Aberdeen University Research Archive (Aberdeen University) (submittedVersion)
  • UCL Discovery (University College London) (submittedVersion)
  • Apollo (University of Cambridge) (submittedVersion, cc-by-nc)
Funders
Health Services and Delivery Research (HS&DR) Programme (RG 68235)
Topics
  • Health Sciences › Medicine › Oncology › Cutaneous Melanoma Detection and Management
  • Health Sciences › Health Professions › General Health Professions › Mobile Health and mHealth Applications
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › melanin and skin pigmentation
Keywords
melanoma detection, mobile health apps, skin self-examination, ABCDE method, melanoma risk assessment, patient education, app validation, mobile health
MeSH terms
Smartphone, Humans, Melanoma, Patient Education as Topic, Skin Neoplasms, Self-Examination, Telemedicine, Risk Assessment, Mobile Applications

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-08.

Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-08.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review